| Product Code: ETC12962757 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Naltrexone Buprenorphine Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Naltrexone Buprenorphine Market Revenues & Volume, 2021 & 2031F |
3.3 China Naltrexone Buprenorphine Market - Industry Life Cycle |
3.4 China Naltrexone Buprenorphine Market - Porter's Five Forces |
3.5 China Naltrexone Buprenorphine Market Revenues & Volume Share, By Formulation Type, 2021 & 2031F |
3.6 China Naltrexone Buprenorphine Market Revenues & Volume Share, By Mechanism of Action, 2021 & 2031F |
3.7 China Naltrexone Buprenorphine Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 China Naltrexone Buprenorphine Market Revenues & Volume Share, By Administration Method, 2021 & 2031F |
3.9 China Naltrexone Buprenorphine Market Revenues & Volume Share, By Patient Group, 2021 & 2031F |
4 China Naltrexone Buprenorphine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about opioid addiction and the need for effective treatment options in China |
4.2.2 Growing government initiatives to combat substance abuse and promote addiction treatment |
4.2.3 Rising demand for medication-assisted treatment (MAT) for opioid use disorder in the country |
4.3 Market Restraints |
4.3.1 Stringent regulations and limited access to prescription medications like naltrexone and buprenorphine in China |
4.3.2 Cultural stigma associated with addiction treatment leading to underreporting and underutilization of MAT |
4.3.3 Lack of healthcare infrastructure and trained professionals to support the widespread adoption of MAT in the country |
5 China Naltrexone Buprenorphine Market Trends |
6 China Naltrexone Buprenorphine Market, By Types |
6.1 China Naltrexone Buprenorphine Market, By Formulation Type |
6.1.1 Overview and Analysis |
6.1.2 China Naltrexone Buprenorphine Market Revenues & Volume, By Formulation Type, 2021 - 2031F |
6.1.3 China Naltrexone Buprenorphine Market Revenues & Volume, By Oral Tablet, 2021 - 2031F |
6.1.4 China Naltrexone Buprenorphine Market Revenues & Volume, By Sublingual Film, 2021 - 2031F |
6.1.5 China Naltrexone Buprenorphine Market Revenues & Volume, By Injectable Form, 2021 - 2031F |
6.1.6 China Naltrexone Buprenorphine Market Revenues & Volume, By Implant, 2021 - 2031F |
6.1.7 China Naltrexone Buprenorphine Market Revenues & Volume, By Combination Form, 2021 - 2031F |
6.2 China Naltrexone Buprenorphine Market, By Mechanism of Action |
6.2.1 Overview and Analysis |
6.2.2 China Naltrexone Buprenorphine Market Revenues & Volume, By Opioid Receptor Modulation, 2021 - 2031F |
6.2.3 China Naltrexone Buprenorphine Market Revenues & Volume, By Partial Agonist, 2021 - 2031F |
6.2.4 China Naltrexone Buprenorphine Market Revenues & Volume, By Long-Acting Effect, 2021 - 2031F |
6.2.5 China Naltrexone Buprenorphine Market Revenues & Volume, By Sustained Release, 2021 - 2031F |
6.2.6 China Naltrexone Buprenorphine Market Revenues & Volume, By Dual Mechanism, 2021 - 2031F |
6.3 China Naltrexone Buprenorphine Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 China Naltrexone Buprenorphine Market Revenues & Volume, By Opioid Dependence, 2021 - 2031F |
6.3.3 China Naltrexone Buprenorphine Market Revenues & Volume, By Withdrawal Management, 2021 - 2031F |
6.3.4 China Naltrexone Buprenorphine Market Revenues & Volume, By Relapse Prevention, 2021 - 2031F |
6.3.5 China Naltrexone Buprenorphine Market Revenues & Volume, By Maintenance Therapy, 2021 - 2031F |
6.3.6 China Naltrexone Buprenorphine Market Revenues & Volume, By Detoxification, 2021 - 2031F |
6.4 China Naltrexone Buprenorphine Market, By Administration Method |
6.4.1 Overview and Analysis |
6.4.2 China Naltrexone Buprenorphine Market Revenues & Volume, By Oral, 2021 - 2031F |
6.4.3 China Naltrexone Buprenorphine Market Revenues & Volume, By Sublingual, 2021 - 2031F |
6.4.4 China Naltrexone Buprenorphine Market Revenues & Volume, By Injection, 2021 - 2031F |
6.4.5 China Naltrexone Buprenorphine Market Revenues & Volume, By Subcutaneous, 2021 - 2031F |
6.4.6 China Naltrexone Buprenorphine Market Revenues & Volume, By Oral, 2021 - 2031F |
6.5 China Naltrexone Buprenorphine Market, By Patient Group |
6.5.1 Overview and Analysis |
6.5.2 China Naltrexone Buprenorphine Market Revenues & Volume, By Adults, 2021 - 2031F |
6.5.3 China Naltrexone Buprenorphine Market Revenues & Volume, By Teenagers, 2021 - 2031F |
6.5.4 China Naltrexone Buprenorphine Market Revenues & Volume, By Elderly, 2021 - 2031F |
6.5.5 China Naltrexone Buprenorphine Market Revenues & Volume, By Critical Patients, 2021 - 2031F |
6.5.6 China Naltrexone Buprenorphine Market Revenues & Volume, By All Ages, 2021 - 2031F |
7 China Naltrexone Buprenorphine Market Import-Export Trade Statistics |
7.1 China Naltrexone Buprenorphine Market Export to Major Countries |
7.2 China Naltrexone Buprenorphine Market Imports from Major Countries |
8 China Naltrexone Buprenorphine Market Key Performance Indicators |
8.1 Number of government-funded addiction treatment programs incorporating naltrexone and buprenorphine |
8.2 Percentage increase in the number of healthcare professionals trained in MAT administration |
8.3 Patient retention rates in MAT programs using naltrexone and buprenorphine |
9 China Naltrexone Buprenorphine Market - Opportunity Assessment |
9.1 China Naltrexone Buprenorphine Market Opportunity Assessment, By Formulation Type, 2021 & 2031F |
9.2 China Naltrexone Buprenorphine Market Opportunity Assessment, By Mechanism of Action, 2021 & 2031F |
9.3 China Naltrexone Buprenorphine Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 China Naltrexone Buprenorphine Market Opportunity Assessment, By Administration Method, 2021 & 2031F |
9.5 China Naltrexone Buprenorphine Market Opportunity Assessment, By Patient Group, 2021 & 2031F |
10 China Naltrexone Buprenorphine Market - Competitive Landscape |
10.1 China Naltrexone Buprenorphine Market Revenue Share, By Companies, 2024 |
10.2 China Naltrexone Buprenorphine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here